Aster DM Healthcare has announced that it has received 96.68 per cent voting approval from shareholders for the proposed Scheme of Amalgamation with Quality Care India Limited (QCIL). The proposal also received majority support from minority shareholders and creditors.
The approval follows shareholder support for the share swap preceding the merger. According to the company, the merger is expected to be completed in the next quarter after receiving the remaining regulatory and statutory approvals from the National Company Law Tribunal (NCLT).
Commenting the strong positive voting, Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare said, “The strong support from our shareholders reflects their confidence in the strategic rationale of this merger and the long-term value it will deliver. By bringing together Aster DM Healthcare and Quality Care India, we are building a scaled, future-ready healthcare platform with the clinical depth, operational strength and governance framework required to serve millions of patients across the country. This partnership combines Aster’s legacy of patient-centric care and physician leadership with the institutional strength and growth expertise of Blackstone. Together, we are well positioned to expand access to high-quality healthcare, invest in clinical excellence and innovation, and create one of India’s leading integrated healthcare networks.”
Upon completion of the merger, the combined entity is expected to operate across 9 states and 28 cities. The merged platform will include 39 hospitals with more than 10,625 beds and will be supported by over 36,307 employees and clinicians. The company stated that the network will serve patients through hospitals, clinics, laboratories and allied healthcare services.
India remains Aster’s largest growth market. The merged entity plans to increase total bed capacity to around 14,710 beds in the coming years. Out of the planned addition of more than 4,080 beds by the combined platform, approximately 2,368 beds will be added by Aster while the remaining expansion will be driven by QCIL. Aster’s expansion will be supported by a capital outlay of around ₹2,300 crore, of which ₹350 crore had already been invested in projects as of September 2025.
The company plans to add around 2,368 beds through greenfield projects and acquisitions. These additions will support expansion in states including Kerala and Karnataka. The company plans to establish two hospitals in Bengaluru, including a 430-bed facility on Sarjapur Road and a 500-bed hospital in Yeshwanthpur. Bed capacity will also increase by 350 beds at Aster CMI Hospital and by 159 beds at Aster Whitefield.
In Kerala, the 263-bed Aster Kasaragod Hospital became operational in October 2025. The 454-bed greenfield Aster Capital Hospital in Trivandrum is under development. Aster Medcity in Kochi is also undergoing expansion with the addition of 100 beds. Other projects include a 300-bed Women & Children’s Hospital in Hyderabad and a 75-bed expansion at Aster Ramesh Hospital in Ongole.